SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-213898
Filing Date
2018-07-06
Accepted
2018-07-06 17:16:35
Documents
3
Period of Report
2018-07-03
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d671411d8k.htm 8-K 19686
2 EX-99.1 d671411dex991.htm EX-99.1 9757
3 GRAPHIC g671411regulus.jpg GRAPHIC 7967
  Complete submission text file 0001193125-18-213898.txt   41871
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 18943036
SIC: 2834 Pharmaceutical Preparations